| Stage | MYRG | % of rev | MTZ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $5.2B | 100.00% | MTZ ×4.09 |
| Gross profit | $171M | 13.60% | $661M | 12.83% | MYRG +0.8pp |
| Operating income | $85M | 6.76% | $275M | 5.35% | MYRG +1.4pp |
| Pre-tax income | $82M | 6.54% | $220M | 4.27% | MYRG +2.3pp |
| Net income | $60M | 4.77% | $168M | 3.26% | MYRG +1.5pp |
| Stage | MYRG | MTZ | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $5.2B100.00% | MTZ ×4.09 |
| Gross profit | 13.60%$171M | 12.83%$661M | MYRG +0.8pp |
| Operating income | 6.76%$85M | 5.35%$275M | MYRG +1.4pp |
| Pre-tax income | 6.54%$82M | 4.27%$220M | MYRG +2.3pp |
| Net income |
| 4.77%$60M |
| 3.26%$168M |
| MYRG +1.5pp |
No disclosed counterparties: MYRG, MTZ.